Member Info for MIKODX

I think we will get some news soon. The Nasdaq listing is yet to hit a dollar. The sec wouldn't have granted RNLX more time to get and stay at $1 for at least ten days if the company didn't have something up their sleeve. I believe we will get news early next month the lates, which will make six months since the company has been in a takeover period. Six months is normally the time most companies take to make a decision in a takeover period.

100K for the company’s first stroke test sales is not bad at all. The first sales of the AIHL was 20K, within a year that increased over tenfold to over 200K. If the stroke test is distributed at the same rate as the AIHL we could be turning over sales iover a million within the first year. Great news.

In 2022 GDR was turning over 20K. In H2 2023 turnover increased to 240K a massive increase due to increased sales of the AIHL. With expansion still ongoing and now CYP2C19-ID recommended by NICE, sales can only improve from here. If we can get to the 0.5M mark in H1 2024, then this will be further proof that the company is moving in the right direction. With a yearly cashburn of 3.5M, there's still a long way to go before they can stand on their own two feet. However, the two outstanding products already on the market being used by the NHS puts the company in an exclusive space, a space the majority of other companies would love to be in.

With end of year results coming up, we will see where the company is as regards sales of the AIHL, where we are with expansion, status of the FDA application, and projected sales of the CYP2C19-ID. The company will have to find a way of reducing the monthly cashburn if they want to start reaping the benefits of increased turnover. With AI now in the game, this should be more than possible. If the company can improve sales and keep costs down, then things are not looking at all bad for GDR. With current dire market conditions, the SP could remain low, but if the market picks up then the SP could rise very quickly here. The company still has sound fundamentals in place, even if the SP is not reflecting that. A lot going on, and a lot to look forward to here in my opinion.

I know I'm a bit late with this one, but I'm very surprised this has happened. No reason's been given, so it seems, he either resigned abruptly or was quickly pushed out the door. Whichever one it is I'm glad he's gone, especially if it was him that insisted on the recent massive share dilution, which has crippled the SP and devalued investors investments. Say what you want about Budd, he always managed to keep the company afloat with minimum dilution, yet somehow Cheek came along and messed that all up. We had a drawdown facility already in motion and could have continued with it but Cheek decided against it. I think Gino has the company's best interests at heart and will make the decisions that will benefit the company, not take it backwards.

Market conditions affect the SP much more than trade volumes. If the market is buoyant, then so are shares. If there's a big selloff and market conditions are not good, as I mentioned in my previous comment, then the SP will drop. It's also an opportunity to buy in cheap, that's if you think it will eventually rise higher. If the buying continues to outweigh the selling, it will eventually rise, at least it should.

Most stocks have been down last couple of days after weak US manufacturing data sparked a global selloff. London stocks fell at the open on today following heavy losses in Asia, as investors eyed the latest US non-farm payrolls report.

That's why this has taken off yet as we expected. Once the dust settles we should clear 5p imo.

Much prefer a nice steady rise, than a quick spike up and then down again. I'm confident this will start to rise once the market has had time to digest this news. The potential to Genedrive is massive.

This is the one the company has been waiting for, for years. This is a breakthrough test which will most definitely be adopted throughout the NHS. I think more so than the MT-RNR1 ID, simply because there are more stroke victims than there are newborn babies requiring genetic testing to prevent hearing loss.

The test will save the NHS 160M a year. The potential for GDR would be huge. This is a fantastic achievement for the company, which will not only benefit them financially, but will benefit the public in general. This test will save lives, and for that we have to say a massive thank you to Genedrive PLC. Their hard work and dedication has now been rewarded. Great to be involved with a company that is saving lives through their expertise and innovation. Expect to see this one really take off in the months ahead. It's Onwards and Up from here.

Fantastic news today, things are finally taking shape for GDR across the pond. The device designation program means we are not too far away from being granted full FDA approval. For more about this program click on the following link:

https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program#s2

This hit 0.0010 then bounced up, and it's still going up. I noticed out of 2.3B shares there's only 54.3M free float. Wonder if that has anything to do with the sudden rise. Added to that the volumes traded over the last four days have been huge. Wish I knew what was going on, these low capped stocks just dont do what you expect them to. When they fall down, the drop is jaw dropping and when they rise they take off like a rocket. Right now this is taking off fast, and as longs as it keeps rising you wont hear me complaining.

Let's not forget, today was the day we should have had the NICE announcement about the stroke test. Hopefully we push on from here leading up to the announcement at the end of the month.

Https://www.tipranks.com/stocks/rnlx/forecast

I've seen plenty of companies delist from the Nasdaq. They normally drop down into the OTC or pink sheets market where they continue to trade. Some companies have done very well in this market. It's basically the American version of the AIM, so not the end of the world. I'm going to continue to hold the stock which is a risk but a risk I've already weighed up and factored in when I invested. The only positive thing going for this so far is that the major institutions are still invested. Mount Sinai is the biggest holder so far with 24% of the total shares. According to Simply Wall Street, in the last three months 3.5M shares have been sold and 9.4M bought by institutions, so they must know something we don't.

I managed to get out of SDRY before it crashed, but not so lucky here. This looked a good buy with a bidding war going on. Now it's looking like it was just a ploy to hike the SP and cash in by way of a Placing. Only news of a firm bid can turn this around now, however, with the way the company have behaved so far, that's looking highly unlikely.

Then in February they announce that a big pharma company is interested in buying out the shares. Was this a ploy to attract investors and hike up the SP to attain Nasdaq compliancy? With the Nasdaq delisting now coming to light, are the company not obligated to let shareholders know what the position is with external offers? Looks to me like there has been some unfair play going on here and deliberate attempts to hoodwink investors. Surely the FCA should investigate what is happening here, and why shareholders were not informed of the Nasdaq situation.

Renalytix announces that as previously disclosed on December 22nd 2023?

Problem is, there was no announcement on December 22nd 2023 warning of this. Could this be a breech of FCA rules?

The Guy just cannot help himself, the cup is forever half empty, lol.

Wow, wasn't expecting an answer that quickly. They were obviously in it for a quick profit.

Guy - I never said I dont make negative comments about the company. I do when it's neccessary, but I also make positive comments when I see the company making good progress. You on the other hand have never said anything positive about the company, even when it warrants it. All your comments are negative and always putting the company down. You spent a good amount of time trawling through my comments trying to find a negative comment I made. You had to dig all the way back to May 10th. One has to look no further than this page to see the utter vile you speak against the company, every comment you make is negative. Are you not ashamed?

Ok mikodx I guess you are back in as you bash this relentlessly when your not,shameless.

No I'm not back in, fact is I've never been out. Nothing has changed except I've averaged down. I have to laugh when I hear you say I bash this company relentlessly. One only has to read your latest comments to see that all you do is bash the company. Never ever heard you say anything good about the company. Even in your following comments, you continue to bash the company, and you accuse me of doing it. Are you not ashamed?